Claypoole Robert E
SEC insider (Form 3/4/5 filer). CIK 0002005474. President and CEO at Bioventus Inc. (BVS). 10 reported Form 4/5 transactions since Sep 2024; latest on Mar 13, 2026. Located in DURHAM, NC.
Companies Claypoole Robert E has filed insider reports for
- Bioventus Inc. (BVS): Director, Officer, President and CEO
Claypoole Robert E
CIK: 0002005474
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Bioventus Inc.
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Mar 13, 2026BVS
Bioventus Inc.
AwardDirectStock Option (Right to Buy)
309K shares- - Mar 13, 2026BVS
Bioventus Inc.
AwardDirectRestricted Stock Units
278K shares- - Mar 13, 2026BVS
Bioventus Inc.
ExerciseDirect33.5K shares- - Mar 13, 2026BVS
Bioventus Inc.
Tax PaymentDirect14.6K shares at avg. $8.62$125K - Jan 9, 2026BVS
Bioventus Inc.
ExerciseDirect93.8K shares- - Jan 9, 2026BVS
Bioventus Inc.
Tax PaymentDirect41.7K shares at avg. $8.03$335K - Mar 14, 2025BVS
Bioventus Inc.
AwardDirectRestricted Stock Units
134K shares- - Mar 14, 2025BVS
Bioventus Inc.
AwardDirectStock Option (Right to Buy)
153K shares- - Jan 13, 2025BVS
Bioventus Inc.
SaleDirect28.8K shares at avg. $9.10$262K - Jan 10, 2025BVS
Bioventus Inc.
ExerciseDirect93.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 13, 2026 | BVS Bioventus Inc. | Award Stock Option (Right to Buy) | 309,000 | - | - | Direct |
| Mar 13, 2026 | BVS Bioventus Inc. | Award Restricted Stock Units | 278,000 | - | - | Direct |
| Mar 13, 2026 | BVS Bioventus Inc. | Exercise | 33,500 | - | $0 | Direct |
| Mar 13, 2026 | BVS Bioventus Inc. | Tax Payment | 14,553 | $8.62 | $125,447 | Direct |
| Jan 9, 2026 | BVS Bioventus Inc. | Exercise | 93,750 | - | $0 | Direct |
| Jan 9, 2026 | BVS Bioventus Inc. | Tax Payment | 41,717 | $8.03 | $334,988 | Direct |
| Mar 14, 2025 | BVS Bioventus Inc. | Award Restricted Stock Units | 134,000 | - | - | Direct |
| Mar 14, 2025 | BVS Bioventus Inc. | Award Stock Option (Right to Buy) | 153,000 | - | - | Direct |
| Jan 13, 2025 | BVS Bioventus Inc. | Sale | 28,786 | $9.10 | $261,953 | Direct |
| Jan 10, 2025 | BVS Bioventus Inc. | Exercise | 93,750 | - | $0 | Direct |
1-10 of 10 transactions